Restless legs syndrome: Diagnostik assessment and the advantages and risks of dopaminergic treatment (Journal of Neurology (2006) 253, Suppl. 4, (IV/22-IV/28) DOI: 10.1007/s00415-006-4005-3);Restless legs syndrome: Diagnostic assessment and the advantages and risks of dopaminergic treatment

Journal of Neurology

Volumn 253, Issue SUPPL. 4, 2006, Pages 1444-

  Högl, Birgit ^a   Paulus, Walter ^b   Clarenbach, Peter ^c   Trenkwalder, Claudia ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Augmentation; Dopamine receptors; Iron; Periodic limb movements (PLM); Spinal

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LEVODOPA; MAGNESIUM; NEUROLEPTIC AGENT; OPIATE;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DRUG OVERDOSE; HUMAN; LIMB MOVEMENT; PAIN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; STRUCTURED INTERVIEW;

EID: 33748309186     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0082-9     Document Type: Erratum

References (54)

1. Abetz L, Arbuckle R, Allen RP, Garcia-Borreguero D, Hening W, Walters AS, Mavraki E, Kirsch JM (2006) The reliability, validity and responsiveness of the International RLS Study Group rating scale and subscales in a clinical trial setting. Sleep Med 7:340-349
2. Abetz L, Vallow SM, Kirsch J, Allen RP, Washburn T, Earley CJ (2005) Validation of the Restless Legs Syndrome Quality of Life questionnaire. Value Health 8(2):157-167
3. Allen RP, Earley CJ (1996) Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19:205-213
4. Allen RP, Earley CJ (2001) Validation of the Johns Hopkins restless legs severity scale. Sleep Med 2:239-242
5. Allen RP, Kushida CA, Atkinson MJ (2003) RLS QoL Consortium Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity. Sleep Med 4(2):133-135
6. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J (2003) Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4(2):101-119
7. Atkinson MJ, Allen RP, DuChane J, Murray C, Kushida C, Roth T (2004) RLS Quality of Life Consortium Validation of the restless legs syndrome quality of life instrument (RLS-QLI): findings a consortium of national experts and the RLS foundation. Qual Life Res 13(3): 679-693
8. Atlas Task Force of the American Sleep Disorders Association (1993) Recording and scoring of leg movements. Sleep 16:748-759
9. Benes H, Kaulfuss L, Muchalski T, Kohnen R (2005) Validation of an algorithm for the diagnosis of the restless legs syndrome (RLS): the restless legs syndrome diagnostic index (RLS-DI). Sleep 28: A274
10. Benes H, Kohnen R (2004) The Restless Legs Syndrome Diagnostic Index (RLS-DI).Mov Disord 19: S419
11. Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G (2003) Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 126:1485-1492
12. Chesson AL Jr,Wise M, Davila D, Johnson S, Littner M, Anderson WM, Hartse K, Rafecas J (1999) Practice parameters for the treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Report. Standards of Practice Committee of the Academy of Sleep Medicine. Sleep 22:961-968
13. Clardy SL, Earley CJ, Allen RP, Beard JL, Connor JR (2006) Ferritin subunits in CSF are decreased in restless legs syndrome. J Lab Clin Med 147:67-73
14. Davis BJ, Rajput A, Rajput ML, Aul EA, Eichhorn GR (2000) A randomized, double-blind, placebo-controlled trial of iron in restless legs syndrome. Eur Neurol 43:70-75
15. Earley CJ, Connor JR, Beard JL, Clardy SL, Allen RP (2005) Ferritin levels in the cerebrospinal fluid and restless legs syndrome: effects of different clinical phenotypes. Sleep 28:1069-1075
16. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP (2000) Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54(8):1698-1700
17. Earley CJ, Heckler D, Allen RP (2004) The treatment of restless legs syndrome with intravenous iron dextran. Sleep Med 5:231-235
18. Ferini-Strambi L, Oldani A, Castronovo V (2001) RLS augmentation and pramipexole long-term treatment. Neurology 56(Suppl 3):A20 (abstract)
19. Ferri R, Zucconi M, Manconi M, et al. (2006) New approaches to the study of periodic leg movements during sleep in restless legs syndrome. Sleep 29:759-769
20. Garcia-Borreguero D, Högl B, Ferini-Strambi L, Hadjigeorgiou G, Hornyak M, de Weerd A, Happe S, Stiasny Kolster K, Trenkwalder C, Allen R, Kohnen R (2005) Validation of the Augmentation Severity Rating Scale (ASRS): First results from a study of the European Research RLS Group (EU-RLSG). Sleep Med 6(S2):S67
21. Gschliesser V, Brandauer E, Ulmer H, Poewe W, Högl B (2006) Periodic limb movement counting in polysomnography: effects of amplitude. Sleep Med 7:249-254
22. Guilleminault C, Mondini S, Montplaisir J, Mancuso J, Cobasko D, Dement WC (1987) Periodic leg movement, L-dopa, 5-hydroxytryptophan, and L-tryptophan. Sleep 10:393-397
23. Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M (1999) The treatment of restless legs syndrome and periodic limb movement disorder. Sleep 22:970-999
24. Hening WA, Allen RP, Earley CJ, Pichietti DL, Silber MH and Restless Legs Syndrome Task Force of Practice Committee of the American Academy of Sleep Medicine (2004) An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27:560-583
25. Högl B, Garcia-Borreguero D, Gschliesser V, Cabrero B, Kohnen R, Allen RP (2005) On the development of the "Structured Interview for Diagnosis of Augmentation during RLS treatment" (RLS-SIDA): First experiences. Sleep Med 5(S2):S158
26. Högl B, Kiechl S, Willeit J, Saletu M, Frauscher B, Seppi K, Muller J, Rungger G, Gasperi A, Wenning G, Poewe W (2005) Restless legs syndrome: a community-based study of prevalence, severity, and risk factors. Neurology 64:1920-1924
27. Högl B, Poewe W (2005) Restless legs syndrome. Curr Opin Neurol 18(4):405-410
28. Hornyak M, Feige B, Riemann D, Voderholzer U (2006) Periodic leg movements in sleep and periodic limb movement disorder: Prevalence, clinical significance and treatment. Sleep Med Rev 10:169-177
29. Hornyak M, Riemann D, Vorderholzer U (2006) Magnesium therapy in patients with idiopathic restless legs syndrome: A placebo-controlled, randomized, double blind study. Sleep 29:A289
30. Kaplan PW, Allen RP, Buchholz DW, Walters JK (1993) A double-blind placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. Sleep 16:717-723
31. Kohnen R, Benes H, Heinrich CR, Kurella B (2002) Development of the disease-specific Restless Legs Syndrome Quality of Life (RLS-QoL) questionnaire. Mov Disord 17(S5):A232
32. Kohnen R, Oertel WH, Stiasny-Kolster K, et al. (2004) Severity rating of RLS: Validation of RLS six scales. Sleep 27:A304
33. Kohnen R, Oertel WH, Stiasny-Kolster K, et al. (2003) Severity rating of restless legs syndrome: review of ten years experience with the RLS-6 scales in clinical trials. Sleep 26:A342
34. Kushida C, Tolson J (2006) Ropinirole is an Effective Treatment for Patients with Restless Legs Syndrome (RLS) Needing Extended Treatment Coverage. Abstract AAN. Neurology 66(Suppl)
35. Lavigne GJ, Montplaisir JY (1994) Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep 17:739-743
36. Lesage S, Hening WA (2004) The restless legs syndrome and periodic limb movement disorder: a review of management. Semin Neurol 24:249-259
37. Lugaresi E, Coccagna G, Tassinari CA, Ambrosetto C (1965) Polygraphic data on motor phenomena in the restless legs syndrome. Rivista di Neurologia 35:550-561
38. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P (1997) Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 12:61-65
39. O'Keeffe ST, Gavin K, Lavan JN (1994) Iron status and restless legs syndrome in the elderly. Age Aging 23:200-203
40. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F (2005).Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers 80:319-324
41. Paulus W, Schomburg ED (2006) Dopamine and the spinal cord in Restless Legs Syndrome: Does spinal cord physiology reveal a basis of augmentation? Sleep Medicine Reviews 10(3):185-196
42. Paulus W, Trenkwalder C (2006) Less is more: Therapy-related augmentation of symptoms in Restless Legs Syndrome caused by dopaminergic overstimulation. Lancet Neurology (in press)
43. Pennestri M, Montplaisir J, Richard M, Rompre S, Colombo R, Lanfranchi PA (2006) Differetial rise of blood pressure in periodic leg movements associated or not with micro-arousals in patients with restless legs syndrome. Sleep 29: A290-291
44. Rye D (2006) What should we be measuring? Defining the "P" in PLMS. Sleep 29:741-742
45. Rye D, Hicks A, Kristjansson K, et al. (2005) Population-based confirmation of the 12q locus in Iceland. Sleep 28:A277-278
46. Santamaria J, Pranzo A, Tolosa E (2003) Development of restless legs sindrome after dopaminergic treatment in a patient with periodic leg movements in sleep. Sleep Med 4:153-155
47. Symonds CP (1953) Nocturnal myoclonus. J Neurol Neurosurg Psychiatry 16:166-171
48. Trenkwalder C, Paulus W (2004) Why do restless legs occur at rest? - pathophysiology of neuronal structures in RLS.Neurophysiology of RLS (part 2). Clin Neurophysiol 115:1975-1988
49. Trenkwalder C, Paulus W, Walters AS (2005) The restless legs syndrome. Lancet Neurol 4:465-475
50. Venugopalan VV, Ghali Z, Senecal J, Reader TA, Descarries L (2006) Catecholaminergic activation of G-protein coupling in rat spinal cord: further evidence for the existence of dopamine and noradrenaline receptors in spinal grey and white matter. Brain Res 1070(1):90-100
51. Walters AS and The International Restless Legs Syndrome Study Group (1995) Toward a better definition of restless legs syndrome. Mov Disord 10:634-642
52. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C (2003) International Restless Legs Syndrome Study Group Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4(2):121-132
53. Winkelman JW (1999) The evoked heart rate response to periodic leg movements of sleep. Sleep 22:575-580
54. Zucconi M, Ferri R, Allen R, Baier PC, Bruni O, Chokroverty S, Ferini-Strambi L, Fulda S, Garcia-Borreguero D, Hening WA, Hirshkowitz M, Högl B, Hornyak M, King M, Montagna P, Parrino L, Plazzi G, Terzano MG (2006) International Restless Legs Syndrome Study Group (IRLSSG), The official World Association of Sleep Medicine (WASM) Standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG). Sleep Med 7:175-183